These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26681525)

  • 1. Evaluating three hundred and fifty-two admissions and predictors of re-admissions for epistaxis - is it time to re-evaluate tranexamic acid in epistaxis?
    Jervis S; Saunders T; Belcher J; Skinner D
    Clin Otolaryngol; 2017 Apr; 42(2):439-442. PubMed ID: 26681525
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic Acid for Epistaxis--A Promising Treatment That Deserves Further Study.
    Clinkard D; Barbic D
    CJEM; 2016 Jan; 18(1):72-3. PubMed ID: 26088087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
    Utkewicz MD; Brunetti L; Awad NI
    Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic acid and bevacizumab in hereditary hemorrhagic telangiectasia patients presenting with epistaxis.
    Lacout A; Marcy PY; El Hajjam M; Lacombe P
    Cutis; 2013 Apr; 91(4):173-4. PubMed ID: 23763075
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of tranexamic acid in a patient with hereditary hemorrhagic telangiectasia and massive epistaxis].
    Pérez del Molino A; Zarrabeitia R; Fernández A; Botella LM
    Med Clin (Barc); 2004 Jun; 123(3):118-9. PubMed ID: 15225479
    [No Abstract]   [Full Text] [Related]  

  • 7. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
    Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
    Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET 1: Tranexamic acid in epistaxis: who bloody nose?
    Penrose N; May G
    Emerg Med J; 2016 Nov; 33(11):823-825. PubMed ID: 28319931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal tranexamic acid for the treatment of hereditary hemorrhagic telangiectasia: a case report and review of treatment options.
    Flanagan BA; Collins C; Parra S
    Cutis; 2012 Feb; 89(2):69-72. PubMed ID: 22474728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
    Bridwell RE; April MD; Long B
    Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
    [No Abstract]   [Full Text] [Related]  

  • 12. Tranexamic acid in epistaxis: a systematic review.
    Kamhieh Y; Fox H
    Clin Otolaryngol; 2016 Dec; 41(6):771-776. PubMed ID: 26946067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study.
    Geisthoff UW; Seyfert UT; Kübler M; Bieg B; Plinkert PK; König J
    Thromb Res; 2014 Sep; 134(3):565-71. PubMed ID: 25005464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial.
    Reuben A; Appelboam A; Stevens KN; Vickery J; Ewings P; Ingram W; Jeffery AN; Body R; Hilton M; Coppell J; Wainman B; Barton A
    Ann Emerg Med; 2021 Jun; 77(6):631-640. PubMed ID: 33612282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease.
    Gaillard S; Dupuis-Girod S; Boutitie F; Rivière S; Morinière S; Hatron PY; Manfredi G; Kaminsky P; Capitaine AL; Roy P; Gueyffier F; Plauchu H;
    J Thromb Haemost; 2014 Sep; 12(9):1494-502. PubMed ID: 25040799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Effectiveness of Nasal Compression With Tranexamic Acid Compared With Simple Nasal Compression and Merocel Packing: A Randomized Controlled Trial.
    Akkan S; Çorbacıoğlu ŞK; Aytar H; Emektar E; Dağar S; Çevik Y
    Ann Emerg Med; 2019 Jul; 74(1):72-78. PubMed ID: 31080025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Tranexamic Acid (TXA) Effective Compared with Anterior Nasal Packing (ANP) in Achieving Cessation of Bleeding in Patients with Anterior Epistaxis?
    Torres E; Johnson MY; Seebald K; Kachhi P
    J Emerg Med; 2022 Jun; 62(6):820-825. PubMed ID: 35545485
    [No Abstract]   [Full Text] [Related]  

  • 18. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
    Hilton L; Reuben A
    Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
    Klepfish A; Berrebi A; Schattner A
    Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
    [No Abstract]   [Full Text] [Related]  

  • 20. BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.
    Fox H; Hunter F
    Emerg Med J; 2015 Dec; 32(12):969-70. PubMed ID: 26598634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.